Kovack Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Sell
10,355
-10,955
-51% -$556K 0.02% 620
2026
Q1
$1.14M Buy
21,310
+10,294
+93% +$605K 0.06% 325
2025
Q4
$685K Buy
11,016
+2,418
+28% +$149K 0.03% 486
2025
Q3
$517K Sell
8,598
-2,279
-21% -$139K 0.05% 320
2025
Q2
$681K Sell
10,877
-999
-8% -$60K 0.07% 260
2025
Q1
$715K Buy
11,876
+1
+0% +$62 0.08% 228
2024
Q4
$693K Buy
11,875
+1,251
+12% +$74.3K 0.07% 239
2024
Q3
$629K Sell
10,624
-449
-4% -$25.6K 0.07% 254
2024
Q2
$621K Buy
11,073
+1
+0% +$56 0.07% 258
2024
Q1
$649K Buy
11,072
+49
+0.4% +$2.77K 0.08% 214
2023
Q4
$595K Sell
11,023
-1,179
-10% -$57.6K 0.07% 264
2023
Q3
$592K Sell
12,202
-4,031
-25% -$214K 0.08% 225
2023
Q2
$916K Sell
16,233
-1,682
-9% -$92.6K 0.12% 166
2023
Q1
$967K Sell
17,915
-144
-0.8% -$7.67K 0.13% 154
2022
Q4
$949K Sell
18,059
-6,109
-25% -$310K 0.14% 151
2022
Q3
$1.14M Sell
24,168
-2,162
-8% -$112K 0.17% 136
2022
Q2
$1.33M Sell
26,330
-12,386
-32% -$675K 0.18% 127
2022
Q1
$2.36M Buy
38,716
+460
+1% +$27.4K 0.24% 87
2021
Q4
$2.52M Buy
38,256
+3,736
+11% +$239K 0.24% 94
2021
Q3
$2.17M Sell
34,520
-58
-0.2% -$3.7K 0.24% 110
2021
Q2
$2.08M Sell
34,578
-4,932
-12% -$285K 0.24% 110
2021
Q1
$2.17M Sell
39,510
-71,892
-65% -$3.99M 0.28% 94
2020
Q4
$6.08M Buy
111,402
+2,160
+2% +$113K 0.87% 13
2020
Q3
$5.46M Sell
109,242
-15,684
-13% -$760K 0.97% 15
2020
Q2
$5.51M Buy
124,926
+16,086
+15% +$687K 1.07% 12
2020
Q1
$4.09M Buy
108,840
+87,144
+402% +$3.67M 0.94% 13
2019
Q4
$956K Buy
21,696
+588
+3% +$24.7K 0.17% 149
2019
Q3
$870K Buy
21,108
+1,140
+6% +$46.7K 0.18% 147
2019
Q2
$801K Sell
19,968
-582
-3% -$22K 0.18% 133
2019
Q1
$793K Buy
20,550
+4,260
+26% +$155K 0.2% 129
2018
Q4
$543K Buy
16,290
+1,278
+9% +$44.3K 0.16% 156
2018
Q3
$569K Buy
15,012
+438
+3% +$15.6K 0.15% 175
2018
Q2
$487K Buy
14,574
+648
+5% +$21.1K 0.14% 181
2018
Q1
$429K Buy
13,926
+2,124
+18% +$65.4K 0.11% 223
2017
Q4
$341K Sell
11,802
-3,948
-25% -$114K 0.09% 273
2017
Q3
$439K Buy
15,750
+330
+2% +$9.13K 0.15% 167
2017
Q2
$428K Buy
15,420
+2,400
+18% +$63.5K 0.14% 182
2017
Q1
$329K Buy
13,020
+900
+7% +$21.8K 0.13% 178
2016
Q4
$269K Buy
12,120
+1,830
+18% +$41.5K 0.13% 176
2016
Q3
$249K Buy
+10,290
New +$245K 0.12% 194

Other funds holding IHI

Kovack Advisors's IHI Position: Q2 2026 in Review

Kovack Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 51% in Q2 2026, selling an estimated $556K and leaving 10,355 shares worth $516K. The position accounts for 0.02% of the portfolio, ranked #620.

Kovack Advisors first reported a position in IHI in Q3 2016 and has held it in 40 quarters since. The position peaked at $6.08M in Q4 2020. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Kovack Advisors held 10,355 shares of iShares US Medical Devices ETF worth $516K as of Q2 2026.
  • Kovack Advisors sold 10,955 iShares US Medical Devices ETF shares in Q2 2026, an estimated $556K.
  • iShares US Medical Devices ETF made up 0.02% of Kovack Advisors's portfolio in Q2 2026, its #620 holding.
  • Kovack Advisors first reported a position in iShares US Medical Devices ETF in Q3 2016 and has held it in 40 quarters since.
  • Kovack Advisors's iShares US Medical Devices ETF position peaked at $6.08M in Q4 2020.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.